Literature DB >> 28695442

Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.

Timmy Lee1,2.   

Abstract

The vascular access is the lifeline for the hemodialysis patient. In the United States, the Fistula First Breakthrough Initiative (FFBI) has been influential in improving use of arteriovenous fistulas (AVF) in prevalent hemodialysis patients. Currently, prevalent AVF rates are near the goal of 66% set forth by the original FFBI. However, central venous catheter (CVC) rates remain very high in the United States in patients initiating hemodialysis, nearly exceeding 80%. A new direction of the of the FFBI has focused on strategies to reduce CVC use, and subsequently the FFBI has now been renamed the "Fistula First-Catheter Last Initiative". However, an AVF may not be the best vascular access in all hemodialysis patients, and arteriovenous grafts (AVG) and CVCs may be appropriate and the best access for a subset of hemodialysis patients. Unfortunately, there still remains very little emphasis within vascular access initiatives and guidelines directed towards evaluation of the individual patient context, specifically patients with poor long-term prognoses and short life expectancies, patients with multiple comorbidities, patients who are more likely to die than reach end stage renal disease (ESRD), and patients of elderly age with impaired physical and cognitive function. Given the complexity of medical and social issues in advanced CKD and ESRD patients, planning, selection, and placement of the most appropriate vascular access are ideally managed within a multidisciplinary setting and requires consideration of several factors including national vascular access guidelines. Thus, the evolution of the FFBI should underscore the need for multidisciplinary health teams with a major emphasis placed on "the right access for the right patient" and improving the patient's overall quality of life.

Entities:  

Keywords:  Arteriovenous fistula; Arteriovenous graft; Fistula first; Hemodialysis catheter; Hemodialysis vascular access

Mesh:

Year:  2017        PMID: 28695442      PMCID: PMC5693683          DOI: 10.1007/s13239-017-0319-9

Source DB:  PubMed          Journal:  Cardiovasc Eng Technol        ISSN: 1869-408X            Impact factor:   2.495


  84 in total

1.  Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report.

Authors:  Kevan Roy Polkinghorne; Mechelle Seneviratne; Peter G Kerr
Journal:  Am J Kidney Dis       Date:  2008-09-21       Impact factor: 8.860

2.  "Eligibility" is key word in Fistula First Breakthrough Initiative in determining fistula use.

Authors:  Lesley Dinwiddie
Journal:  Nephrol News Issues       Date:  2006-08

3.  When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration?

Authors:  A M O'Hare; D Bertenthal; L C Walter; A X Garg; K Covinsky; J S Kaufman; R A Rodriguez; M Allon
Journal:  Kidney Int       Date:  2007-01-24       Impact factor: 10.612

4.  Improving incident fistula rates: a process of care issue.

Authors:  Timmy Lee; Prabir Roy-Chaudhury; Charuhas V Thakar
Journal:  Am J Kidney Dis       Date:  2011-06       Impact factor: 8.860

Review 5.  Epidemiology and management of end-stage renal disease in the elderly.

Authors:  Edwina A Brown; Lina Johansson
Journal:  Nat Rev Nephrol       Date:  2011-08-30       Impact factor: 28.314

Review 6.  Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

7.  Effect of change in vascular access on patient mortality in hemodialysis patients.

Authors:  Michael Allon; John Daugirdas; Thomas A Depner; Tom Greene; Daniel Ornt; Steve J Schwab
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

8.  Hemodialysis vascular access morbidity in the United States.

Authors:  H I Feldman; P J Held; J T Hutchinson; E Stoiber; M F Hartigan; J A Berlin
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

Review 9.  The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.

Authors:  Anton N Sidawy; Lawrence M Spergel; Anatole Besarab; Michael Allon; William C Jennings; Frank T Padberg; M Hassan Murad; Victor M Montori; Ann M O'Hare; Keith D Calligaro; Robyn A Macsata; Alan B Lumsden; Enrico Ascher
Journal:  J Vasc Surg       Date:  2008-11       Impact factor: 4.268

Review 10.  Hemodialysis central venous catheter dysfunction.

Authors:  Micah R Chan
Journal:  Semin Dial       Date:  2008-09-24       Impact factor: 3.455

View more
  14 in total

1.  Improved Patency of ePTFE Grafts as a Hemodialysis Access Site by Seeding Autologous Endothelial Cells Expressing Fibulin-5 and VEGF.

Authors:  Itai Tzchori; Mizied Falah; Denis Shteynberg; Dana Levin Ashkenazi; Zeev Loberman; Luba Perry; Moshe Y Flugelman
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

2.  Provision of Kidney Disease Education Service Is Associated with Improved Vascular Access Outcomes among US Incident Hemodialysis Patients.

Authors:  Rupam Ruchi; Shahab Bozorgmehri; Gajapathiraju Chamarthi; Tatiana Orozco; Rajesh Mohandas; Tezcan Ozrazgat-Baslanti; Mark S Segal; Ashutosh M Shukla
Journal:  Kidney360       Date:  2021-09-28

3.  A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility study.

Authors:  Mariana Murea; Randolph L Geary; Denise K Houston; Matthew S Edwards; Todd W Robinson; Ross P Davis; Justin B Hurie; Timothy K Williams; Gabriela Velazquez-Ramirez; Benjamin Bagwell; Audrey B Tuttle; Shahriar Moossavi; Michael V Rocco; Barry I Freedman; Jeff D Williamson; Haiying Chen; Jasmin Divers
Journal:  Pilot Feasibility Stud       Date:  2020-06-17

4.  Prevalence and correlates of central venous catheter use among haemodialysis patients in the Irish health system - a national study.

Authors:  Wael F Hussein; Husham Mohammed; Leonard Browne; Liam Plant; Austin G Stack
Journal:  BMC Nephrol       Date:  2018-04-02       Impact factor: 2.388

5.  A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification.

Authors:  Linda Awdishu; Teri Moore; Michelle Morrison; Christy Turner; Danuta Trzebinska
Journal:  Pharmacy (Basel)       Date:  2019-07-03

6.  Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial.

Authors:  Pavlina Richtrova; Jan Mares; Lukas Kielberger; Jan Klaboch; Jaromir Eiselt; Tomas Reischig
Journal:  BMC Nephrol       Date:  2021-01-28       Impact factor: 2.388

7.  Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.

Authors:  Matthew R Sinclair; Maria Souli; Felicia Ruffin; Lawrence P Park; Michael Dagher; Emily M Eichenberger; Stacey A Maskarinec; Joshua T Thaden; Michael Mohnasky; Christina M Wyatt; Vance G Fowler
Journal:  Am J Kidney Dis       Date:  2021-07-23       Impact factor: 8.860

8.  Vascular Access and Risk of Bloodstream Infection Among Older Incident Hemodialysis Patients.

Authors:  Sophia V Kazakova; James Baggs; Ibironke W Apata; Sarah H Yi; John A Jernigan; Duc Nguyen; Priti R Patel
Journal:  Kidney Med       Date:  2020-03-16

9.  Supply and Distribution of Vascular Access Physicians in the United States: A Cross-Sectional Study.

Authors:  Shoou-Yih D Lee; Jie Xiang; Abhijit V Kshirsagar; Diane Steffick; Rajiv Saran; Virginia Wang
Journal:  Kidney360       Date:  2020-08-27

Review 10.  Sex Differences in Inflammation During Venous Remodeling of Arteriovenous Fistulae.

Authors:  Shin Mei Chan; Gabe Weininger; John Langford; Daniel Jane-Wit; Alan Dardik
Journal:  Front Cardiovasc Med       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.